Oncotelic Therapeutics (OTLC) Share-based Compensation (2010 - 2025)
Oncotelic Therapeutics (OTLC) reported Share-based Compensation of $2.2 million for Q4 2025.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Share-based Compensation (2010 - 2025) Analysis & Trends
For FY2025, Oncotelic Therapeutics posted Share-based Compensation of $2.38 million.
- Share-based Compensation has a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $902,141 in FY2022 (+18.2%) and $763,315 in FY2021 (-64.5%).
- The Q4 2025 figure ranks as the highest quarterly Share-based Compensation in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | - |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 183,742.00 |
| Dec 31, 2022 | 902,141.00 |
| Sep 30, 2022 | 303,687.00 |
| Jun 30, 2022 | 25,196.00 |
| Mar 31, 2022 | 297,360.00 |
| Dec 31, 2021 | 900,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 2.09 Mn |
| Mar 31, 2020 | 2.15 Mn |
| Mar 31, 2019 | 418,136.00 |
| Dec 31, 2018 | 213,878.00 |
| Sep 30, 2018 | 242,311.00 |
| Jun 30, 2018 | 111,689.00 |
| Mar 31, 2018 | 184,000.00 |
| Dec 31, 2017 | 193,000.00 |
| Sep 30, 2017 | 196,000.00 |
| Jun 30, 2017 | 206,000.00 |
| Mar 31, 2017 | 240,000.00 |
| Dec 31, 2016 | 177,000.00 |
API Access
Oncotelic Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();